Patent details

LUC00016 Product Name: Ruxolitinib, ou un sel pharmaceutiquement acceptable de celui-ci

Basic Information

Publication number:
LUC00016
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP111527305
Legal Status:
Inactive
Application number:
LUC00016
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/12/773/001-016
Marketing Authorization Type:
Marketing Authorization Date:
13/03/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
24/04/2017
First Marketing Authorization date:
13/03/2015
Grant date:
07/08/2017
Activation date:
Publication date:
26/04/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
13/03/2030
SPC Extension Expiration:
13/03/2030
Rejection date:
Withdrawal date:

Owner

From:
24/04/2017
 
 

Name:
Incyte Holdings Corporation
Address:
1801 Augustine Cut-Off, Wilmington, DE 19803, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
24/04/2017
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2017/02
Publication date:
22/06/2017
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2017/05
Publication date:
13/09/2017
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/12/2026
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
15/12/2021 Incoming Correspondence (Post) 2
24/04/2017 General Document 2
24/04/2017 General Document 3
24/04/2017 General Document 1
24/04/2017 General Document 46
24/04/2017 General Document 1
26/04/2017 Publication 1
24/04/2017 General Document 18
24/04/2017 General Document 4
24/04/2017 Application Form 5